1.
Civitareale
D
,
Lonigro
R
,
Sinclair
AJ
,
Di Lauro
R
. A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter . EMBO J.
1989; ; 8 : :2537.-2542.
2.
Lazzaro
D
,
Price
M
,
de Felice
M
,
Di Lauro
R
. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain . Development.
1991; ; 113 : :1093.-1104.
3.
Kimura
S
,
Hara
Y
,
Pineau
T
, et al.. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary . Genes Dev.
1996; ; 10 : :60.-69.
4.
Katoh
R
,
Kawaoi
A
,
Miyagi
E
, et al.. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization . Mod Pathol.
2000; ; 13 : :570.-576.
5.
Bejarano
PA
,
Nikiforov
YE
,
Swenson
ES
,
Biddinger
PW
. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms . Appl Immunohistochem Mol Morphol.
2000; ; 8 : :189.-194.
6.
Ziad
el A
,
Ruchala
M
,
Breborowicz
J
, et al.. Immunoexpression of TTF-1 and Ki-67 in a coexistent anaplastic and follicular thyroid cancer with rare long-life surviving . Folia Histochem Cytobiol.
2008; ; 46 : :461.-464.
7.
Ohmori
M
,
Ohta
M
,
Shimura
H
, et al.
Cloning of the single strand DNA-binding protein important for maximal expression and thyrotropin (TSH)-induced negative regulation of the TSH receptor . Mol Endocrinol.
1996; ; 10 : :1407.-1424.
8.
Fabbro
D
,
Di Loreto
C
,
Beltrami
CA
, et al.. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms . Cancer Res.
1994; ; 54 : :4744.-4749.
9.
Fenton
CL
,
Patel
A
,
Burch
HB
,
Tuttle
RM
,
Francis
GL
. Nuclear localization of thyroid transcription factor-1 correlates with serum thyrotropin activity and may be increased in differentiated thyroid carcinomas with aggressive clinical course . Ann Clin Lab Sci.
2001; ; 31 : :245.-252.
10.
Lv
H
,
Zhang
S
,
Wang
B
,
Cui
S
,
Yan
J
. Toxicity of cationic lipids and cationic polymers in gene delivery . J Control Release.
2006; ; 114 : :100.-109.
11.
Gudmundsson
J
,
Sulem
P
,
Gudbjartsson
DF
, et al.
Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations . Nat Genet.
2009; ; 41 : :460.-464.
12.
Chen
G
,
Jiang
Q
,
You
Z
, et al.
Regulation of GSK-3 beta in the proliferation and apoptosis of human thyrocytes investigated using a GSK-3 beta-targeting RNAi adenovirus expression vector: involvement the Wnt/beta-catenin pathway . Mol Biol Reports.
2010; ; 37 : :2773.-2779.
13.
Bohinski
RJ
,
Bejarano
PA
,
Balko
G
,
Warnick
RE
,
Whitsett
JA
. Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1 . J NeuroOncol.
1998; ; 40 : :227.-231.
14.
Kwei
KA
,
Kim
YH
,
Girard
L
, et al.
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer . oncogene.
2008; ; 27 : :3635.-3640.
15.
Garraway
LA
,
Sellers
WR
. Lineage dependency and lineage-survival oncogenes in human cancer . Nat Rev Cancer.
2006; ; 6 : :593.-602.
16.
Asa
SL
. My approach to oncocytic tumours of the thyroid . J Clin Pathol.
2004; ; 57 : :225.-232.
17.
Oliveira
AM
,
Tazelaar
HD
,
Myers
JL
, et al.
Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites . Am J Surg Pathol.
2001; ; 25 : :815.-819.
18.
Ordonez
NG
. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas . Adv Anat Pathol.
2000; ; 7 : :123.-127.
19.
Jagirdar
J
. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung . Arch Pathol Lab Med.
2008; ; 132 : :384.-396.
20.
Marchevsky
AM
. Application of immunohistochemistry to the diagnosis of malignant mesothelioma . Arch Pathol Lab Med.
2008; ; 132 : :397.-401.
21.
Byrd-Gloster
AL
,
Khoor
A
,
Glass
LF
, et al.
Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor . Hum Pathol.
2000; ; 31 : :58.-62.
22.
Puglisi
F
,
Aprile
G
,
Bruckbauer
M
, et al.
Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas . Cancer Lett.
2001; ; 162 : :97.-103.
23.
Barletta
JA
,
Perner
S
,
Iafrate
AJ
, et al.
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma . J Cell Mol Med.
2009; ; 13 : :1977.-1986.
24.
Anagnostou
VK
,
Syrigos
KN
,
Bepler
G
, et al.
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma . J Clin Oncol.
2009; ; 27 : :271.-278.
25.
Kitamura
H
,
Yazawa
T
,
Sato
H
, et al.
Small cell lung cancer: significance of RB alterations and TTF-1 expression in its carcinogenesis, phenotype, and biology . Endocr Pathol.
2009; ; 20 : :101.-107.
26.
Zhang
P
,
Zuo
H
,
Nakamura
Y
, et al.
Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors . Pathol Int.
2006; ; 56 : :240.-245.
27.
Ngan
ES
,
Lang
BH
,
Liu
T
, et al.. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma . J Natl Cancer Inst.
2009; ; 101 : :162.-175.
28.
Puglisi
F
,
Barbone
F
,
Damante
G
, et al.
Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma . Mod Pathol.
1999; ; 12 : :318.-324.